H Yanai, H Adachi, M Hakoshima, H Katsuyama - Metabolites, 2023 - ncbi.nlm.nih.gov
Beyond lowering plasma glucose levels, sodium–glucose cotransporter 2 inhibitors
(SGLT2is) significantly reduce hospitalization for heart failure (HF) and retard the …